V8 Peptides — Engineered Performance
Research Library
KPV Tripeptide Chemistry: Formula, Synthesis, Analysis
KPVChemistry

KPV Tripeptide Chemistry: Formula, Synthesis, Analysis

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What is the chemistry of the KPV tripeptide? KPV (Lys-Pro-Val) has the formula C16H30N4O4 and an average molecular weight of about 342.4 g/mol. Short peptides like it are made by solid-phase synthesis with a protected lysine side chain; relevant side-reactions include diketopiperazine formation, and the salt form affects cell assays. For laboratory research use only.

KPV is one of the simplest peptides a chemist can make, and that simplicity is why its chemistry is a good teaching case. Three residues, one proline, no disulfide bond, no modification. This article explains how a tripeptide such as Lys-Pro-Val is assembled, what the formula and molecular weight mean, which chemical side-reactions are relevant to such a short sequence, and what analytical methods answer the question of whether a vial contains what it says. It describes general chemistry in the literature and is not a manufacturing procedure. For laboratory research use only; not for human consumption.

The KPV research vials page lists Lys-Pro-Val, molecular formula C16H30N4O4, as a lyophilized powder in 5 mg and 10 mg vials with ≥98% purity by HPLC. Biological background is in the KPV research overview; analytical reading is covered in KPV purity testing and understanding HPLC purity; notation is in understanding amino acid sequences.

Formula, mass and composition

The molecular formula C16H30N4O4 can be reconstructed from its parts. The three free amino acids are lysine (C6H14N2O2), proline (C5H9NO2) and valine (C5H11NO2). Joining three amino acids forms two peptide bonds, and each bond releases one molecule of water. The sums are: carbon 6 + 5 + 5 = 16; hydrogen 14 + 9 + 11 − 4 = 30; nitrogen 2 + 1 + 1 = 4; oxygen 2 + 2 + 2 − 2 = 4. The result matches the formula on the product page.

QuantityValueHow it is obtained
FormulaC16H30N4O4Sum of residues minus two H2O
Average molecular weightAbout 342.4 g/molSum of atomic weights
Monoisotopic massAbout 342.23 DaSum of the most abundant isotope masses; used in mass spectrometry
Residues3 (K, P, V)Sequence Lys-Pro-Val, N- to C-terminus
Peptide bonds2Lys–Pro and Pro–Val

These numbers are for the free peptide. A supplied salt form includes a counterion and some water, so the mass of the whole solid is larger than the mass of the peptide alone.

How short peptides are built: solid-phase synthesis

Most research peptides are made on a solid support. In the original solid-phase method, a tetrapeptide was assembled by attaching the first amino acid to an insoluble polymer and extending the chain one residue at a time, with soluble reagents and by-products washed away after each step [1]. Modern practice follows that principle. A widely used protocol is based on the Fmoc/tBu strategy, activation of carboxyl groups with aminium-derived coupling reagents, and PEG-modified polystyrene resins, and the same paper discusses special techniques needed for difficult sequences where growing chains aggregate [2]. An overview of solid-phase synthesis of biologically relevant peptides covers the choices in resin, coupling and cleavage [4].

A tripeptide such as KPV is not a difficult sequence in that sense: it is too short to aggregate on the resin. Its challenges are different, and they are about the side chain and the ends of the molecule.

Protecting groups: why lysine needs one

In chain assembly, every reactive group other than the one being coupled must be masked. Lysine has a second amino group on its side chain, which would react like the α-amino group if left exposed, so the side chain is protected during synthesis and the protection is removed at the end. Reviews of amino-acid protecting groups catalog the options and the reasons behind pairing them so that one set can be removed without disturbing another [3]. For KPV the practical result is that a correct product requires complete removal of the side-chain protecting group; an incompletely deprotected lysine would give an impurity with the same sequence and a different mass, which is why mass-sensitive analysis is useful.

Side-reactions relevant to a proline-containing tripeptide

IssueWhat it isRelevance to KPV
Diketopiperazine formationThe N-terminal dipeptide cyclizes and is cleaved from the chainReported for the model tripeptide Ala-Pro-Met, with rate increasing at higher pH [6]; KPV also has proline in position 2, but was not tested
Incomplete deprotectionA protecting group remains on a side chainGives a higher-mass impurity; detectable by mass
Deletion sequencesA coupling step failed, leaving a shorter peptideGives Lys-Val, Pro-Val or Lys-Pro fragments; separable by HPLC
RacemizationA residue changes configuration during activationGives diastereomers that can co-elute; needs a chiral or high-resolution method
Counterion carryoverAcid from cleavage or HPLC remains as the saltTrifluoroacetate affected cultured cell proliferation in one study [5]

The Ala-Pro-Met study is useful because it measured the diketopiperazine reaction in a tripeptide at 37 °C and at two pH values, finding first-order kinetics and higher rates at higher pH, and it noted that the reaction was slower in the intact protein than in the model peptide [6]. A short peptide is therefore a more sensitive reporter of this reaction than a large molecule is.

Purification and the counterion

After cleavage from the resin, a crude peptide is purified, usually by reversed-phase HPLC with an acidic ion-pairing solvent. Peptides purified in this way are often obtained as trifluoroacetate salts, and the authors of the osteoblast study reported that the TFA salts reduced proliferation compared with hydrochloride salts in cultures at concentrations at and above 10-8 M [5]. The counterion is therefore a chemistry detail with experimental consequences, and the supplied form for any lot should be confirmed from the documentation instead of assumed. how to reconstitute a lyophilized peptide and the article on KPV lab handling cover the practical side; here the point is that the molecular weight used in calculations should match the actual salt form when it is known.

Analytical questions and which method answers them

QuestionMethod that addresses itNot answered by
How pure is the main peak?Reversed-phase HPLC with UV detectionIdentity of the main peak
Is the mass right (342.4 g/mol)?Mass spectrometryQuantity or the position of residues
Is the sequence Lys-Pro-Val and not an isomer?Tandem mass spectrometry or amino-acid analysisPurity by itself
How much peptide per mg of solid?Amino-acid analysis or nitrogen contentIdentity
Is it stable?Stress testing with repeat HPLC [7]Single-time-point data

Forced-degradation work, in which a sample is exposed to stresses such as elevated temperature, freeze-thawing, oxidation and light and re-analyzed, is the standard way to learn what changes a molecule can undergo [7]. For KPV the relevant outcomes would be the diketopiperazine product and any hydrolysis fragments. Product-page statements describe purity by HPLC; what each method can and cannot show is explained in HPLC vs mass spectrometry and how to read a COA, and batch documentation, where published, is on the COA page.

Reading a mass-spectrum result for a tripeptide

For a molecule this small, the mass-spectrometry result is easy to interpret, which makes it a good first identity check. In positive-ion mode the protonated molecule appears at a mass-to-charge ratio about one unit above the neutral monoisotopic mass, near 343.2, and sodium or potassium adducts appear at higher values. Larger peptides spread their signal over many charge states; a tripeptide carries one or two charges, so the pattern is simple. A peak at the expected value is consistent with the right composition, but it cannot by itself distinguish Lys-Pro-Val from an isomer with the same residues in a different order, such as Val-Pro-Lys. Fragment ions from tandem mass spectrometry, which break the chain at its bonds, are what separate the isomers, and the fragment masses can be predicted in advance from the sequence.

Purity and quantity need separate evidence. A chromatogram shows the proportion of the main peak among detected species, while the quantity of peptide in a weighed amount of solid requires a content method, because water and counterion can account for a substantial fraction of the mass. For this reason the arithmetic in a lab notebook should state whether concentrations are based on the labeled mass or on a measured net content. The calculation itself is the same formula in either case (concentration equals mass divided by volume), and the reconstitution calculator applies it to whichever mass is entered.

What chemistry cannot tell you about biology

A well-characterized molecule is a precondition, not a result. Chemistry shows that a vial contains Lys-Pro-Val at a stated purity; it does not show that any biological effect follows. The reported biology, for example NF-κB signaling in cultured cells, is described in the article on KPV and NF-κB, and the broader overview is in the KPV research overview. For labs using the compound in experiments, the useful habits are to quote the formula and molecular weight, state the salt form and basis of concentration, and keep the batch documentation with the data.

Frequently asked questions

What is the chemical formula of KPV?

C16H30N4O4, as listed on the product page, corresponding to an average molecular weight of about 342.4 g/mol.

How is a short peptide like KPV made?

By solid-phase synthesis: the chain is assembled residue by residue on an insoluble support, then cleaved, deprotected and purified.

Why does lysine need a protecting group?

Lysine has a second amino group on its side chain that would otherwise react during chain assembly, so it is masked and later unmasked.

What is diketopiperazine formation?

A cyclization in which the N-terminal dipeptide of a chain cleaves off as a ring. It was reported for a proline-containing model tripeptide, with higher rates at higher pH.

Why does the salt form matter?

Counterions such as trifluoroacetate add mass and, in one cell study, affected proliferation, so cell assays should account for them.

Does a 98% HPLC purity confirm the sequence?

No. HPLC measures the proportion of the main peak; identity needs mass spectrometry or another method.

What is monoisotopic mass?

The mass calculated from the most abundant isotope of each element, the value seen in high-resolution mass spectrometry; it is about 342.23 Da for KPV.

What kinds of impurities occur in short peptides?

Deletion sequences, incompletely deprotected products, racemized forms and salt or water content, depending on the synthesis.

Is this a synthesis protocol?

No. It summarizes published general chemistry and is not a manufacturing procedure.

Where do I see lot documentation?

On the COA page, where published.

Related reading: KPV Tripeptide Research Guide: Evidence and Gaps, KPV vs Other Peptides: Choosing Research Comparators, KPV in Tissue Injury and Repair Models: Evidence Map.

References

  1. Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J. Am. Chem. Soc.. 1963;85(14):2149-2154. doi:10.1021/ja00897a025
  2. Coin I, Beyermann M, Bienert M. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nat Protoc. 2007;2(12):3247-3256. doi:10.1038/nprot.2007.454
  3. Isidro-Llobet A, Álvarez M, Albericio F. Amino Acid-Protecting Groups. Chem. Rev.. 2009;109(6):2455-2504. doi:10.1021/cr800323s
  4. Palomo JM. Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides. RSC Adv.. 2014;4(62):32658-32672. doi:10.1039/C4RA02458C
  5. Cornish J, Callon KE, Lin CQX, Xiao CL, Mulvey TB, Cooper GJS, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology-Endocrinology and Metabolism. 1999;277(5):E779-E783. doi:10.1152/ajpendo.1999.277.5.E779
  6. Goolcharran C, Jones AJS, Borchardt RT. Comparison of the rates of deamidation, diketopiperazine formation, and oxidation in recombinant human vascular endothelial growth factor and model peptides. AAPS PharmSci. 2000;2(1):42-47. doi:10.1208/ps020105
  7. Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler Hc, Jiskoot W. Forced Degradation of Therapeutic Proteins. Journal of Pharmaceutical Sciences. 2012;101(3):895-913. doi:10.1002/jps.22812

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.